bioRxivBioengineering
Thermostability and binding properties of single-chained Fv fragments derived from therapeutic antibodies
T. Tadokoro, H. Tsuboi, K. Nakamura, T. Hayakawa, R. Ohmura, I. Kato, M. Inoue, S.-i. Tsunoda, S. Niizuma, Y. Okada, S. Otsuguro, K. Maenaka
Abstract
Small antibody fragments have recently been used as alternatives to full-length monoclonal antibodies in therapeutic applications. One of the most popular fragment antibodies is single-chain fragment variables (scFvs), consisting of variable heavy (VH) and variable light (VL) domains linked by a flexible peptide linker. scFvs have small molecular sizes, which enables good tissue penetration and low immunogenicity. Despite these advantages, the use of scFvs, especially for therapeutic purpose, is still limited because of the difficulty to regulate the binding activity and conformational stability. In this study, we constructed and analyzed 10 scFv fragments derived from 10 representatives of FDA-approved mAbs to evaluate their physicochemical properties. Differential scanning calorimetry analysis showed that scFvs exhibited relatively high but varied thermostability, from 50 to 70 {degrees}C of melting temperatures, and different unfolding cooperativity. Surface plasmon resonance analysis revealed that scFvs fragments that exhibit high stability and cooperative unfolding likely tend to maintain antigen binding. This study demonstrated the comprehensive physicochemical properties of scFvs derived from FDA-approved antibodies, providing insights into antibody design and development.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Insights into the stability of a therapeutic antibody Fab fragment by molecular dynamics and its stabilization by computational design
- Towards generalizable prediction of antibody thermostability using machine learning on sequence and structure features
Ameya Harmalkar, Roshan Rao, … Kathy Y. Wei·mAbsPeer-reviewed·Jan 22, 2023
- Strategies to improve scFvs as crystallization chaperones suggested by analysis of a complex with the human PHD-bromodomain SP140
M. Fairhead, C. Preger, … S. Graslund·bioRxiv·Sep 13, 2019
- Development and Biophysical Characterization of a Humanized FSH-Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra-High Concentration
S. Rojekar, A. R. Pallapati, … M. Zaidi·eLifePeer-reviewed·Jun 19, 2023
- Survey of Chemical Unfolding Complexity as a Unique Stability Assessment Assay for Monoclonal Antibodies
J. Alaina Floyd, Jeremy M. Shaver·Analytical BiochemistryPeer-reviewed·Nov 29, 2024
- Enhancement of antibody thermostability and affinity by computational design in the absence of antigen
Mark Rowland Hutchinson, Jeffrey A. Ruffolo, … Gilad Kaplan·mAbsPeer-reviewed·Jun 20, 2024